plk3 pbd 335 646 proteins (BPS Bioscience)
BPS Bioscience is a verified supplier 
BPS Bioscience manufactures this product 
93
Structured Review
BPS Bioscience
plk3 pbd 335 646 proteins
Plk3 Pbd 335 646 Proteins, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plk3+pbd+335+646+proteins/PLK3+Polo+Box+Domain%2C+MBP-tag%2C+His-tag+Recombinant/us12415822-162-4-11
Average 93 stars, based on 2 article reviews
Plk3 Pbd 335 646 Proteins, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plk3+pbd+335+646+proteins/PLK3+Polo+Box+Domain%2C+MBP-tag%2C+His-tag+Recombinant/us12415822-162-4-11
Average 93 stars, based on 2 article reviews
plk3 pbd 335 646 proteins - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
In Vitro:Article Title: Small molecule inhibitors selective for polo-like kinase protein Article Snippet: were dissolved in DMSO (10 mM) and diluted from 10 nM to 600 μM (maximum of 6% DMSO tolerance in the assay). .. PLK1 PBD (367-603) and Article Title: Peptidomimetic Polo-Box targeted inhibitors that engage PLK1 in tumor cells and are selective against the PLK3 tumor suppressor. Article Snippet: were optimized following standard guidelines ( http://www.ncbi.nlm.nih.gov/books/NBK92000/ ). .. The PLK1 PBD (367–603) and Article Title: Targeting sub-cellular localization through the Polo-Box Domain: non-ATP competitive Inhibitors recapitulate a PLK1 phenotype Article Snippet: and peptides to be tested were dissolved in DMSO (10 mM), and diluted from 10 nM to 600 µM. .. The PLK1 PBD (367–603) and Binding Assay:Article Title: Small molecule inhibitors selective for polo-like kinase protein Article Snippet: were dissolved in DMSO (10 mM) and diluted from 10 nM to 600 μM (maximum of 6% DMSO tolerance in the assay). .. PLK1 PBD (367-603) and Article Title: Peptidomimetic Polo-Box targeted inhibitors that engage PLK1 in tumor cells and are selective against the PLK3 tumor suppressor. Article Snippet: were optimized following standard guidelines ( http://www.ncbi.nlm.nih.gov/books/NBK92000/ ). .. The PLK1 PBD (367–603) and Article Title: Targeting sub-cellular localization through the Polo-Box Domain: non-ATP competitive Inhibitors recapitulate a PLK1 phenotype Article Snippet: and peptides to be tested were dissolved in DMSO (10 mM), and diluted from 10 nM to 600 µM. .. The PLK1 PBD (367–603) and Sequencing:Article Title: Small molecule inhibitors selective for polo-like kinase protein Article Snippet: were dissolved in DMSO (10 mM) and diluted from 10 nM to 600 μM (maximum of 6% DMSO tolerance in the assay). .. PLK1 PBD (367-603) and Article Title: Peptidomimetic Polo-Box targeted inhibitors that engage PLK1 in tumor cells and are selective against the PLK3 tumor suppressor. Article Snippet: were optimized following standard guidelines ( http://www.ncbi.nlm.nih.gov/books/NBK92000/ ). .. The PLK1 PBD (367–603) and Article Title: Targeting sub-cellular localization through the Polo-Box Domain: non-ATP competitive Inhibitors recapitulate a PLK1 phenotype Article Snippet: and peptides to be tested were dissolved in DMSO (10 mM), and diluted from 10 nM to 600 µM. .. The PLK1 PBD (367–603) and Activity Assay:Article Title: Small molecule inhibitors selective for polo-like kinase protein Article Snippet: were dissolved in DMSO (10 mM) and diluted from 10 nM to 600 μM (maximum of 6% DMSO tolerance in the assay). .. PLK1 PBD (367-603) and Article Title: Peptidomimetic Polo-Box targeted inhibitors that engage PLK1 in tumor cells and are selective against the PLK3 tumor suppressor. Article Snippet: were optimized following standard guidelines ( http://www.ncbi.nlm.nih.gov/books/NBK92000/ ). .. The PLK1 PBD (367–603) and Article Title: Targeting sub-cellular localization through the Polo-Box Domain: non-ATP competitive Inhibitors recapitulate a PLK1 phenotype Article Snippet: and peptides to be tested were dissolved in DMSO (10 mM), and diluted from 10 nM to 600 µM. .. The PLK1 PBD (367–603) and Western Blot:Article Title: Small molecule inhibitors selective for polo-like kinase protein Article Snippet: were dissolved in DMSO (10 mM) and diluted from 10 nM to 600 μM (maximum of 6% DMSO tolerance in the assay). .. PLK1 PBD (367-603) and Article Title: Peptidomimetic Polo-Box targeted inhibitors that engage PLK1 in tumor cells and are selective against the PLK3 tumor suppressor. Article Snippet: were optimized following standard guidelines ( http://www.ncbi.nlm.nih.gov/books/NBK92000/ ). .. The PLK1 PBD (367–603) and Article Title: Targeting sub-cellular localization through the Polo-Box Domain: non-ATP competitive Inhibitors recapitulate a PLK1 phenotype Article Snippet: and peptides to be tested were dissolved in DMSO (10 mM), and diluted from 10 nM to 600 µM. .. The PLK1 PBD (367–603) and |